An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered Without Water Under Fed Compared To Fasted Conditions.
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2014
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors Pfizer
- 11 Jan 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 13 Dec 2010 New trial record